SZSE:301301 (China)
Â
Ordinary Shares Class A
Â¥
13.18
(+20.04%)
Apr 30
Business Description
Yili Chuannig Biotechnology Co Ltd
ISIN : CNE100005WX0
Share Class Description:
SZSE:301301: Ordinary Shares Class ACompare
Compare
Traded in other countries / regions
301301.China IPO Date
2022-12-27Description
Yili Chuannig Biotechnology Co Ltd adopts the most advanced and mature international biological fermentation, chemical extraction, enzymatic hydrolysis, control and energy saving, and environmental protection technology. The main products of the company include erythromycin thiocyanate, cephalosporin intermediates, penicillin intermediates, and crude ursodeoxycholic acid.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.47 | |||||
| Equity-to-Asset | 0.69 | |||||
| Debt-to-Equity | 0.26 | |||||
| Debt-to-EBITDA | 1.36 | |||||
| Interest Coverage | 18.89 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 5.39 | |||||
| Beneish M-Score | -2.54 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.1 | |||||
| 3-Year EBITDA Growth Rate | -6.2 | |||||
| 3-Year EPS without NRI Growth Rate | 54.9 | |||||
| 3-Year FCF Growth Rate | 16.3 | |||||
| 3-Year Book Growth Rate | 10.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 96.21 | |||||
| 9-Day RSI | 90.45 | |||||
| 14-Day RSI | 85.14 | |||||
| 6-1 Month Momentum % | -0.11 | |||||
| 12-1 Month Momentum % | -3.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.76 | |||||
| Quick Ratio | 1.21 | |||||
| Cash Ratio | 0.36 | |||||
| Days Inventory | 128.25 | |||||
| Days Sales Outstanding | 63.7 | |||||
| Days Payable | 86.62 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.71 | |||||
| Dividend Payout Ratio | 0.18 | |||||
| Forward Dividend Yield % | 0.71 | |||||
| 5-Year Yield-on-Cost % | 0.71 | |||||
| 3-Year Average Share Buyback Ratio | -3.6 | |||||
| Shareholder Yield % | 6.9 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 33.78 | |||||
| Operating Margin % | 28.14 | |||||
| Net Margin % | 22.02 | |||||
| FCF Margin % | 23.92 | |||||
| ROE % | 16.58 | |||||
| ROA % | 11.04 | |||||
| ROIC % | 14.67 | |||||
| ROC (Joel Greenblatt) % | 20.16 | |||||
| ROCE % | 18.32 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 26.36 | |||||
| PE Ratio without NRI | 25.54 | |||||
| PS Ratio | 5.81 | |||||
| PB Ratio | 4.01 | |||||
| Price-to-Tangible-Book | 4.14 | |||||
| Price-to-Free-Cash-Flow | 23.46 | |||||
| Price-to-Operating-Cash-Flow | 17.91 | |||||
| EV-to-EBIT | 18.1 | |||||
| EV-to-EBITDA | 18.1 | |||||
| EV-to-Revenue | 5.01 | |||||
| EV-to-FCF | 18.78 | |||||
| Price-to-Graham-Number | 2.17 | |||||
| Price-to-Net-Current-Asset-Value | 26.36 | |||||
| Earnings Yield (Greenblatt) % | 5.52 | |||||
| FCF Yield % | 4.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Yili Chuannig Biotechnology Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 5,076.82 | ||
| EPS (TTM) (Â¥) | 0.5 | ||
| Beta | 0 | ||
| Volatility % | 47.61 | ||
| 14-Day RSI | 85.14 | ||
| 14-Day ATR (Â¥) | 0.532757 | ||
| 20-Day SMA (Â¥) | 9.7215 | ||
| 12-1 Month Momentum % | -3.77 | ||
| 52-Week Range (Â¥) | 6.94 - 13.18 | ||
| Shares Outstanding (Mil) | 2,222.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Yili Chuannig Biotechnology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Yili Chuannig Biotechnology Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Yili Chuannig Biotechnology Co Ltd Frequently Asked Questions
What is Yili Chuannig Biotechnology Co Ltd(SZSE:301301)'s stock price today?
The current price of SZSE:301301 is ¥13.18. The 52 week high of SZSE:301301 is ¥13.18 and 52 week low is ¥6.94.
When is next earnings date of Yili Chuannig Biotechnology Co Ltd(SZSE:301301)?
The next earnings date of Yili Chuannig Biotechnology Co Ltd(SZSE:301301) is .
Does Yili Chuannig Biotechnology Co Ltd(SZSE:301301) pay dividends? If so, how much?
The Dividend Yield %  of Yili Chuannig Biotechnology Co Ltd(SZSE:301301) is 0.71% (As of Today), Highest Dividend Payout Ratio of Yili Chuannig Biotechnology Co Ltd(SZSE:301301) was 0.22. The lowest was 0.18. And the median was 0.22. The  Forward Dividend Yield % of Yili Chuannig Biotechnology Co Ltd(SZSE:301301) is 0.71%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers